Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. (April 2017) - Seymour, J.F.; Buckstein, R.; Santini, V.; Döhner, H.; Stone, R.M.; Minden, M.D.; Kuo, C.Y.; Ben-Yehuda, D.; Bargay, J.; Songer, S.; Weaver, J.; Beach, C.L.; et al.